{
  "Symbol": "ZBH",
  "AssetType": "Common Stock",
  "Name": "Zimmer Biomet Holdings Inc",
  "Description": "Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.",
  "CIK": "1136869",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES",
  "Address": "345 EAST MAIN STREET, WARSAW, IN, US",
  "OfficialSite": "https://www.zimmerbiomet.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "19372579000",
  "EBITDA": "2590300000",
  "PERatio": "21.71",
  "PEGRatio": "1.187",
  "BookValue": "62.62",
  "DividendPerShare": "0.96",
  "DividendYield": "0.01",
  "EPS": "4.43",
  "RevenuePerShareTTM": "37.81",
  "ProfitMargin": "0.118",
  "OperatingMarginTTM": "0.233",
  "ReturnOnAssetsTTM": "0.0465",
  "ReturnOnEquityTTM": "0.0725",
  "RevenueTTM": "7678600000",
  "GrossProfitTTM": "5498900000",
  "DilutedEPSTTM": "4.43",
  "QuarterlyEarningsGrowthYOY": "-0.405",
  "QuarterlyRevenueGrowthYOY": "0.043",
  "AnalystTargetPrice": "122.35",
  "AnalystRatingStrongBuy": "6",
  "AnalystRatingBuy": "5",
  "AnalystRatingHold": "17",
  "AnalystRatingSell": "1",
  "AnalystRatingStrongSell": "1",
  "TrailingPE": "21.71",
  "ForwardPE": "11.7",
  "PriceToSalesRatioTTM": "2.523",
  "PriceToBookRatio": "1.526",
  "EVToRevenue": "3.217",
  "EVToEBITDA": "10.98",
  "Beta": "0.845",
  "52WeekHigh": "122.87",
  "52WeekLow": "93.1",
  "50DayMovingAverage": "105.76",
  "200DayMovingAverage": "107.55",
  "SharesOutstanding": "197841000",
  "DividendDate": "2025-04-30",
  "ExDividendDate": "2025-03-31",
  "Last Updated": "2025-04-23 14:46:06",
  "Price_Day_1": 97.44,
  "Price_Day_2": 96.17,
  "Price_Day_3": 97.92,
  "Price_Day_4": 96.94,
  "Price_Day_5": 97.27,
  "Price_Day_6": 101.97,
  "Price_Day_7": 102.35,
  "Income_totalRevenue_Q1": "2023200000",
  "Income_grossProfit_Q1": "1436500000",
  "Income_netIncome_Q1": "239500000",
  "Income_totalRevenue_Q2": "1824200000",
  "Income_grossProfit_Q2": "1285600000",
  "Income_netIncome_Q2": "249200000",
  "Income_totalRevenue_Q3": "1942000000",
  "Income_grossProfit_Q3": "1178600000",
  "Income_netIncome_Q3": "242800000",
  "Income_totalRevenue_Q4": "1889200000",
  "Income_grossProfit_Q4": "1169400000",
  "Income_netIncome_Q4": "172400000",
  "Balance_totalAssets_Q1": "21365300000",
  "Balance_totalLiabilities_Q1": "6929500000",
  "Balance_totalShareholderEquity_Q1": "14435800000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "525500000",
  "Balance_totalAssets_Q2": "21720300000",
  "Balance_totalLiabilities_Q2": "9337100000",
  "Balance_totalShareholderEquity_Q2": "12374700000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "569000000",
  "Balance_totalAssets_Q3": "21520000000",
  "Balance_totalLiabilities_Q3": "8770500000",
  "Balance_totalShareholderEquity_Q3": "12741100000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "420100000",
  "Balance_totalAssets_Q4": "21452400000",
  "Balance_totalLiabilities_Q4": "8846400000",
  "Balance_totalShareholderEquity_Q4": "12598000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "393000000",
  "Debt to Equity Ratio": 0.48,
  "Is Complete": true
}